Drugs / CLL vaccine using DNA plasmid vector
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00038415 | Dec 2001 → Jul 2004 | chronic lymphocytic leukemia/small lymphocytic lymphoma | M.D. Anderson Cancer Center | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLL vaccine using DNA plasmid vector | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00038415 ↗ |
| Modality | Vaccine | “an antigen delivered by a DNA vaccine” NCT00038415 ↗ |